Pathologists at the Stanford University School of Medicine are trying out a new test from a Sunnyvale company that could give cancer patients a better chance of getting the most effective treatment.
PinPoint's test has been developed with the support of NHS England (image credit: Pixabay) A business behind AI-driven cancer diagnostic software which is designed to "enhance diagnostic accuracy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback